Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2002 | 1 |
2004 | 1 |
2005 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie.
J Clin Oncol. 2004 Jun 15;22(12):2371-8. doi: 10.1200/JCO.2004.06.121.
J Clin Oncol. 2004.
PMID: 15197198
Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Français d'Immunothérapie.
Ravaud A, Delva R, Gomez F, Chevreau C, Douillard JY, Peny J, Coudert B, Négrier S; Groupe Français d'Immunothérapie.
Ravaud A, et al.
Cancer. 2002 Dec 1;95(11):2324-30. doi: 10.1002/cncr.10968.
Cancer. 2002.
PMID: 12436438
Free article.
Clinical Trial.
Item in Clipboard
Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie.
Negrier S, Gomez F, Douillard JY, Ravaud A, Chevreau C, Buclon M, Perol D, Lasset C, Escudier B; Groupe Français d'Immunothérapie.
Negrier S, et al.
World J Urol. 2005 Jul;23(3):161-5. doi: 10.1007/s00345-004-0467-z. Epub 2005 Feb 12.
World J Urol. 2005.
PMID: 15711829
Item in Clipboard
Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial.
Gravis G, Mousseau M, Douillard JY, Dorval T, Fabbro M, Escudier B, Mignot L, Viens P; Groupe Français d'Immunothérapie.
Gravis G, et al.
Eur Cytokine Netw. 2001 Apr-Jun;12(2):239-43.
Eur Cytokine Netw. 2001.
PMID: 11399511
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite